Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2019 | 1 |
2021 | 1 |
2022 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Hodgkin Lymphoma-Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients.
J Clin Med. 2021 Mar 8;10(5):1125. doi: 10.3390/jcm10051125.
J Clin Med. 2021.
PMID: 33800409
Free PMC article.
Review.
AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial.
Sasse S, Bröckelmann PJ, Momotow J, Plütschow A, Hüttmann A, Basara N, Koenecke C, Martin S, Bentz M, Grosse-Thie C, Thorspecken S, de Wit M, Kobe C, Dietlein M, Tresckow BV, Fuchs M, Borchmann P, Engert A.
Sasse S, et al. Among authors: momotow j.
Leuk Lymphoma. 2022 Aug;63(8):1871-1878. doi: 10.1080/10428194.2022.2095623. Epub 2022 Jul 18.
Leuk Lymphoma. 2022.
PMID: 35848865
Clinical Trial.
Item in Clipboard
Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis.
Momotow J, Bühnen I, Trautmann-Grill K, Kobbe G, Hahn D, Schroers R, Heinrich B, Gaska T, Forstbauer H, Schmidt B, Boger R, Hüttmann A, Heil G, Kraemer DM, Krüger W, Zeremski V, Grobe N, Jentsch-Ullrich K, Griesinger F, Fuchs M, von Tresckow B, Borchmann P, Engert A, Bröckelmann PJ.
Momotow J, et al.
Br J Haematol. 2022 Jul;198(2):401-404. doi: 10.1111/bjh.18231. Epub 2022 May 11.
Br J Haematol. 2022.
PMID: 35538912
No abstract available.
Item in Clipboard
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
Jacob AS, Kaul H, Fuchs M, Gillessen S, Kreissl S, Pluetschow A, Momotow J, Schaub V, Huettmann A, Haenel M, Zimmermann A, Dierlamm J, Meissner J, Mathas S, Martin S, Engert A, Hallek M, Borchmann P, Lehmann C.
Jacob AS, et al. Among authors: momotow j.
Infection. 2022 Aug;50(4):925-932. doi: 10.1007/s15010-022-01765-3. Epub 2022 Feb 19.
Infection. 2022.
PMID: 35182355
Free PMC article.
Item in Clipboard
Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition.
Hude I, Sasse S, Bröckelmann PJ, von Tresckow B, Momotow J, Engert A, Borchmann S.
Hude I, et al. Among authors: momotow j.
Br J Haematol. 2018 Jun;181(6):837-840. doi: 10.1111/bjh.14705. Epub 2017 Apr 25.
Br J Haematol. 2018.
PMID: 28439879
Free article.
No abstract available.
Item in Clipboard
Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma - Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center.
Momotow J, Goergen H, Behringer K, Bröckelmann PJ, Borchmann S, Tresckow BV, Kobe C, Engert A, Sasse S.
Momotow J, et al.
Hemasphere. 2019 Sep 27;3(4):e293. doi: 10.1097/HS9.0000000000000293. eCollection 2019 Oct.
Hemasphere. 2019.
PMID: 31942546
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite